Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs.
Joe CCD., Jiang J., Linke T., Li Y., Fedosyuk S., Gupta G., Berg A., Segireddy RR., Mainwaring D., Joshi A., Cashen P., Rees B., Chopra N., Nestola P., Humphreys J., Davies S., Smith N., Bruce S., Verbart D., Bormans D., Knevelman C., Woodyer M., Davies L., Cooper L., Kapanidou M., Bleckwenn N., Pappas D., Lambe T., Smith DC., Green CM., Venkat R., Ritchie AJ., Gilbert SC., Turner R., Douglas AD.
Manufacturing has been the key factor limiting rollout of vaccination during the COVID-19 pandemic, requiring rapid development and large-scale implementation of novel manufacturing technologies. This article is protected by copyright. All rights reserved.